Lipoprotein(a) concentrations in acute myocardial infarction patients are not indicative of levels at six month follow-up.

Efthymios ZiogosMichael A VavuranakisTarek HarbPalmer L ForanMichael J BlahaSteven R JonesShenghan LaiGary GerstenblithThorsten M Leucker

Published in: European heart journal open (2023)

Evolocumab in Acute Coronary Syndrome Trial [EVACS I] NCT03515304, Evolocumab in Patients with Acute Myocardial Infarction [EVACS II], NCT04082442.

Keyphrases